SCHEMBL4257786

SCHEMBL4257786

CCSc1ncccc1Br

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.44
ALDH1A1 P00352 5/20 0.44
KDM4E B2RXH2 3/20 0.44
NPC1 O15118 2/20 0.44
L3MBTL1 Q9Y468 4/20 0.38
HPGD P15428 2/20 0.37
HSD17B10 Q99714 1/20 0.37
ADORA2A P29274 1/20 0.36
LMNA P02545 2/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
CLK1 P49759 1/20 0.34
TDP1 Q9NUW8 4/20 0.33
MAPT P10636 2/20 0.33
PRKAG1 P54619 1/20 0.33
PRKAA1 Q13131 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
PRKAB1 Q9Y478 1/20 0.33
GAA P10253 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16334247 0.78 ALDH1A1 (0.45) SMN1; SMN2ALDH1A1KDM4ENPC1L3MBTL1
SCHEMBL12048608 0.78 KDM4E (0.45) SMN1; SMN2ALDH1A1KDM4ENPC1L3MBTL1
SCHEMBL10834448 0.78 ALDH1A1 (0.45) SMN1; SMN2ALDH1A1KDM4ENPC1L3MBTL1
SCHEMBL2983304 0.77
SCHEMBL805428 0.76 ALDH1A1 (0.44) SMN1; SMN2ALDH1A1KDM4ENPC1L3MBTL1
SCHEMBL15916963 0.76 NPC1 (0.36) SMN1; SMN2ALDH1A1KDM4ENPC1L3MBTL1
SCHEMBL802299 0.74 ALDH1A1 (0.43) SMN1; SMN2ALDH1A1KDM4ENPC1L3MBTL1
SCHEMBL12579033 0.73 MEN1 (0.45) SMN1; SMN2ALDH1A1KDM4ENPC1L3MBTL1
SCHEMBL12579038 0.73 ALDH1A1 (0.42) SMN1; SMN2ALDH1A1KDM4ENPC1L3MBTL1
SCHEMBL12579144 0.73 ALDH1A1 (0.42) SMN1; SMN2ALDH1A1KDM4ENPC1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2046782-A2 IMIDAZOLYLPYRIMIDINE DERIVATIVES FOR TREATMENT OF DISEASES RELATED TO GLYCOGEN SYNTHASE KINASE (GSK3) Astra Zeneca AB (SE) 2009-04-15 EP disclosed
WO-2008002244-A2 IMIDAZOL-PYRIMIDINE DERIVATIVES FOR TREATMENT OF DISEASES RELATED TO GLYCOGEN SYNTHASE KINASE (GSK3) ASTRAZENECA AB (SE) 2008-01-03 WO disclosed